IP Library Granted Patent US 8,034,383
Granted Patent B2
US 8,034,383 · App. 13/015,193 · Granted Oct 11, 2011

Injectable microspheres

Assignee: Cytogel Pharma, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,383
App. No.
13/015,193
Granted
Oct 11, 2011
Kind
B2
Abstract

Injectable microspheres are obtained from double bond functionalized polyhydric alcohol ester by a method comprising dissolving the double bond functionalized esters in a hydrophobic organic solvent, forming an aqueous solution of stabilizer, forming an oil in water emulsion where the solution of stabilizer constitutes the continuous phase and the solution of ester constitutes the disperse phase and evaporating the organic solvent or from block copolymer of PGCLM and methoxy poly(ethylene glycol).

Claims (6)

1. A hardened biodegradable microsphere, in the absence of any organic solvent, formed from multiarm biodegradable polymers wherein the surface of the microsphere is hydrophilic and comprises unsaturated C═C bonds, wherein said microsphere is formed from a double bond functionalized polyhydric alcohol ester of polyester, and wherein said microsphere can be loaded with at least one bioactive agent.

2. The microsphere, according to claim 1 , wherein the surface of the microsphere is converted to a hydrogel.

3. The microsphere, according to claim 2 , comprising a bioactive agent encapsulated in the microsphere, as well as a bioactive agent entrapped within said hydrogel.

4. The biodegradable microsphere, according to claim 1 , having a mean transverse diameter of 5 μM to 200 μm.

5. The biodegradable microsphere, according to claim 4 , having a mean transverse diameter of 15 μm to 60 μm.

6. The biodegradable microsphere, according to claim 1 , which is loaded with 1% to 10% by weight of the microsphere of a drug.

Assignments (1)
CHANGE OF NAME Recorded Sep 9, 2011
From: CYTOGEL, LLC
To: CYTOGEL PHARMA, LLC
Reel/Frame 026877/0113 →
Continuity (3)
Continuation 11148662 · Jun 9, 2005
Provisional Application 60582824 · Jun 28, 2004
Related Publication 20110151004A1 · Jun 23, 2011